相关实验视频
Updated: May 29, 2025

06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
101
皮质类固醇节约局部治疗用环素治疗青少年角质结膜炎
Amarilla Barcsay-Veres1, Anita Csorba2, Illes Kovacs2
1Department of Ophthalmology, Semmelweis University, Maria Str. 39, Budapest, H-1085, Hungary. veres.amarilla@semmelweis.hu.
Scientific reports
|February 7, 2025
概括
局部使用0.1%的环素显著改善了儿科患者的眼睛炎症,这些患者患有过敏和白炎相关的角质结膜炎. 这种治疗减少了对类固醇救援课程的需求,提高了视觉结果.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
背景情况:
- 过敏和白炎引起的眼表面炎症可能会导致角膜问题和视力丧失.
- 类固醇治疗是常见的,但长期使用会带来风险.
研究的目的:
- 评估局部环素0.1%在治疗儿科膜炎的有效性.
- 评估其在过敏和白炎病例中的类固醇节约潜力.
主要方法:
- 一项为期6个月的随访研究包括80名患有中度至重度春季和白炎相关状结膜炎的儿科患者.
- 评估症状 (光敏感性,),症状 (角膜染色,乳头缩) 和患者评估.
- 追踪了救援皮质类固醇使用量的减少.
主要成果:
- 局部使用0.1%的环素显著改善了主观症状和客观症状 (p < 0.001).
- 救援类固醇疗程从3.71大幅下降到0.25在3个月和0.13在6个月 (p <0.001).
- 超过96%的患者经历了良好的或快速和良好的效果,角膜干扰和类固醇依赖性减少.
结论:
- 局部使用0.1%的环素对儿科眼部表面炎症非常有效.
- 它显著减少角膜并发症的复发和需要类固醇治疗的需要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
94
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
94
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
215
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
215
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Angle Closure Glaucoma: Treatment
432
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
432
Open Angle Glaucoma: Treatment
386
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
386
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114

